Stop TB Partnership

Plan an Order

The Stop TB Partnership's Global Drug Facility (STBP/GDF) has established Long Term Agreements with manufacturers of TB medicines with the aim to achieve lower prices and also ensure the sustainable and reliable on-time supply of the full range of the needed TB medicines.

The prices are indicative prices for budgeting purposes. STBP/GDF aims to deliver the TB medicines at these prices or below. The prices are valid through March 2020.

For more information on the TB medicines please refer to the StopTB/GDF catalog.

Download the STBP/GDF Budgeting Prices for TB Medicines

The Stop TB Partnership's Global Drug Facility (STBP/GDF) has established Long Term Agreements with manufacturers of TB diagnostics and laboratory supplies with the aim to achieve lower prices and also ensure the sustainable and reliable on-time supply of the full range of needed products.

Pricing as well as information on product specifications, packaging and shipping information can be found in the GDF TB Diagnostics Ordering List. The List also facilitates order planning by automatically calculating order costs and lead times.

For several new TB diagnostic products, guidance on order planning is available in the series of GDF Technical Information Notes.

For an overview of the full range of TB diagnostics and laboratory supplies available through GDF, please refer to the StopTB/GDF catalog.

This document lays out indicative lead-times for planning purposes for TB products procured via the Stop TB Partnership’s Global Drug Facility (STBP/GDF).

Procurement and delivery lead-time information is the time from order confirmation and receipt of payment by STBP/GDF to delivery to country. This information is provided at the category and detailed product level and is indicative based on current market knowledge to ensure on-time delivery and best value procurement.

Download the Category and Product-level Procurement and Delivery Planning Guide

ISO

GDF is ISO 9001:2015 certified for the provision of quality assured anti-TB drugs and related services to eligible national TB control programmes.